LQAI1.640%
as of Jul 17
PFE
GrowthPFIZER INC
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19.
Close · 3M
-7.68%
Held by 5 AI ETFs
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
Buy signals11
Win rate27% (3/11)
Avg buy return-1.36%
LQAI · Weight increase · 3d
The initial slight reduction followed by a sustained, gradual weight increase from 1.56% to 1.64% over several days characterizes LQAI’s recent positioning in PFE. This methodical accumulation by the LG-Qraft collaboration’s AI-driven selection engine indicates a measured response to PFE’s current market conditions, where the stock trades at $25.05, having recorded negative 30-day and 90-day returns despite being near 88% of its 52-week high. LQAI’s core large-cap strategy, which rebalances weekly without heavy factor tilts, likely identifies PFE’s current valuation, including its PER of 19.06 and ROE of 8.37%, as an attractive entry point after this recent price consolidation. The AI’s consecutive upward adjustments suggest an evolving confidence in PFE as a component within its ~100 US large-cap portfolio, leveraging its specific ranking capabilities to slowly build a position.
weight 1.540% → 1.640% (+0.100 pp)·stock down 3.8% in the 30 days before
Jul 17·entry $25.05·now $24.75Fresh
-1.20%
since Jul 17
LQAI · Weight increase · 2d
PFIZER INC, currently priced at $25.05, sits at 88% of its 52-week high, having experienced negative returns of -2.5% over 30 days and -7.8% over 90 days. Amidst this recent price pressure, the Qraft AI ranking engine, which manages LQAI's ~100 US large-cap core holdings, initiated a series of weight adjustments for PFE. From July 13 to July 16, LQAI consistently increased PFE's allocation, moving from 1.52% to 1.62%, indicating the AI detected a shift or a developing opportunity. Despite PFE's revenue growth of 1.36% and an ROE of 8.37%, this consistent upward adjustment in weight suggests the AI, operating with a core large-cap style rather than a strong momentum bias, found relative value or a fundamental inflection point at this price level. This specific pattern reflects LQAI's unique AI-driven selection methodology pinpointing PFE's potential within its US large-cap universe.
weight 1.540% → 1.620% (+0.080 pp)·stock down 3.3% in the 30 days before
Jul 16·entry $25.14·now $24.75Fresh
-1.55%
since Jul 16
LQAI · Weight decrease · 2d
PFE exhibits a financial profile with a PBR of 1.64, a PER of 18.47, and limited revenue growth at 1.36%, alongside an ROE of 8.37%. This fundamental makeup, representing a large-cap firm with moderate profitability and subdued growth, fits within LQAI's core large-cap universe selected by Qraft's AI ranking, which operates without heavy factor tilts. The consecutive weight decrease observed in LQAI's PFE holding from July 6th to July 10th closely aligns with the stock's recent market performance, where it posted a -7.5% 30-day return and currently trades at $24.17, near 85% of its 52-week high. This suggests Qraft's AI, managing LQAI's weekly rebalances across its ~100 US large-cap portfolio, recalibrated its internal ranking for PFE, likely reducing exposure due to a combination of persistent muted growth signals and the sustained downward price momentum. The AI's action reflects a dynamic adjustment to the stock's evolving risk-reward profile within its specific selection parameters.
weight 1.540% → 1.520% (-0.020 pp)·stock down 6.0% in the 30 days before
Jul 10·entry $24.17·now $24.75
+2.40%
since Jul 10
LQAI · Weight decrease · 2d
LQAI's allocation to PFIZER INC showed a distinct, gradual reduction on July 6th and 7th, shifting from 1.65% to 1.60% and then to 1.54% over consecutive rebalancing entries. This subtle, sustained downtick in weight indicates the Qraft AI ranking engine, which guides LQAI's core large-cap portfolio, has reduced its conviction in PFE, as the stock moves closer to its 52-week low of $23.29 following a -7.1% 30-day return. Operating with a style positioned between broad market exposure and concentrated momentum, the AI engine likely adjusted PFE's rank in response to its recent price depreciation and relatively modest financial figures, such as its 1.36% revenue growth and 8.37% ROE, rather than a single sharp catalyst. The weekly rebalance mechanism allows for such incremental adjustments, signaling the AI system perceives a weakening in PFE's relative attractiveness within the ~100 US large-cap universe without triggering an abrupt divestment.
weight 1.650% → 1.540% (-0.110 pp)·stock down 6.3% in the 30 days before
Jul 7·entry $24.07·now $24.75
+2.83%
since Jul 7
LQAI · Weight increase · 2d
Pfizer's PER of 18.47, PBR of 1.64, 1.36% revenue growth, and 8.37% ROE reflect characteristics suitable for LQAI's core large-cap, AI-driven selection approach, which is designed without heavy factor tilts. The Qraft AI ranking engine, responsible for this ~100 US large-cap portfolio, registered a consecutive weight increase for PFE on July 1st and 2nd, moving from 1.59% to 1.65% within its weekly rebalance. This accumulation coincided with PFE trading at $24.32, sitting at 85% of its 52-week high after experiencing a -5.7% return over 30 days and a -10.4% decline over 90 days. The AI's algorithm, distinct from a concentrated momentum style, likely identified PFE as a favorable inclusion within its balanced universe, given its current valuation and recent price movements.
weight 1.570% → 1.650% (+0.080 pp)·stock down 4.8% in the 30 days before
Jul 2·entry $24.32·now $24.75Fresh
+1.77%
since Jul 2
LQAI · Weight decrease · 2d
The observed pattern in LQAI’s allocation to PFE involves a series of small, iterative decreases, such as the consecutive reductions from 1.62% to 1.56% in late June, punctuated by minor upticks, which aligns with the fund’s weekly rebalancing cycle. This gradual reduction in weight appears to reflect Qraft’s AI ranking system recalibrating PFE’s position within its US large-cap core universe, given the company’s 30-day return of -4.9% and 90-day return of -9.6%. Trading at $24.08, near its 52-week low and with a revenue growth rate of 1.36%, PFE likely presents a less compelling profile for an AI-driven selection engine designed without heavy factor tilts, as its current trajectory may not signal strong near-term catalysts for a core holding. For LQAI, which aims for AI-driven name selection positioned between broad market exposure and concentrated momentum, the persistent softness in PFE’s recent returns and modest financial growth justify these controlled, downward adjustments in allocation rather than a more drastic exit.
weight 1.620% → 1.570% (-0.050 pp)·stock down 8.0% in the 30 days before
Jun 30·entry $24.08·now $24.75
+2.78%
since Jun 30
LQAI · Weight decrease · 2d
LQAI's recent allocation to PFE reveals a pattern of gradual, persistent weight reduction, particularly from 1.74% to 1.56% over the past week, with the most recent consecutive decreases occurring from 1.62% to 1.56%. This steady scaling back aligns with the LG-Qraft AI's weekly rebalancing mechanism, which likely adjusts holdings based on subtle shifts in its proprietary ranking for PFE, currently trading near its 52-week low at $24.29 after a -11.3% 90-day return. The AI-driven name selection, operating without heavy factor tilt, is probably reacting to PFE's modest 1.36% revenue growth and moderate 8.37% ROE, which may not justify a higher allocation given the sustained price weakness. Such a calibrated adjustment suggests the AI is fine-tuning its core exposure to a large-cap company demonstrating decelerating performance, rather than making an abrupt change.
weight 1.660% → 1.560% (-0.100 pp)·stock down 8.4% in the 30 days before
Jun 25·entry $23.67·now $24.75
+4.56%
since Jun 25
LQAI · Weight decrease · 2d
PFE's PER of 18.94, PBR of 1.64, and revenue growth of 1.36% present a financial profile that LQAI's Qraft AI ranking, designed for a core large-cap universe without heavy factor tilts, may find less appealing relative to other US large-cap peers. The fund's Qraft AI ranking led to a weight reduction for PFE from 1.79% on June 10th to 1.70% by June 15th, and after a brief recovery, initiated another consecutive decrease from 1.65% on June 18th to 1.64% by June 22nd. This series of adjustments by the AI's selection engine coincided with PFE experiencing a 30-day return of -2.3% and a 90-day return of -9.6%, with its price settling at $25.08. Operating within a core large-cap universe, LQAI's manager appears to have reduced exposure to PFE as its stock traded at 88% of its 52-week high, suggesting the Qraft system identified declining relative strength signals for the company.
weight 1.740% → 1.640% (-0.100 pp)·stock down 2.8% in the 30 days before
Jun 22·entry $25.08·now $24.75
-1.32%
since Jun 22
LQAI · Weight increase · 2d
LQAI, which utilizes the Qraft AI ranking engine, dynamically rebalances its approximately 100 US large-cap core holdings on a weekly basis. The consecutive weight increases for PFE, rising from 1.73% on June 16th to 1.74% on June 17th, signal the AI's selection engine identified a shift in the stock's attractiveness. Despite PFE's 30-day return of -4.8% and current price of $25.21, the AI likely factored in aspects such as its current PER of 19.18 or its position at 88% of its 52-week high. This AI-driven name selection, operating without a heavy factor tilt, is identifying specific reasons for PFE's increased allocation within its core large-cap universe, moving past earlier reductions.
weight 1.700% → 1.740% (+0.040 pp)·stock up 2.3% in the 30 days before
Jun 17·entry $25.92·now $24.75Fresh
-4.51%
since Jun 17
LQAI · Weight decrease · 3d
Leveraging Qraft's AI ranking applied to its US large-cap core universe, the LQAI ETF made successive adjustments to its Pfizer holding. The fund's weekly rebalancing mechanism reflects the AI's dynamic assessment, leading to a consecutive weight decrease from 1.77% to 1.70% in PFE over the recent period. This movement suggests the AI's model identified diminishing quantitative signals for the company at its current $26.00 price. Specifically, Pfizer's modest 1.36% revenue growth likely contributes to the AI's decision to trim exposure, as the system prioritizes companies with compelling data-driven assessments for its approximately 100 holdings. Such granular, data-driven adjustments are characteristic of LQAI's AI-driven name selection process, which operates without a heavy factor tilt.
weight 1.790% → 1.700% (-0.090 pp)·stock up 1.0% in the 30 days before
Jun 15·entry $26.00·now $24.75
-4.81%
since Jun 15
LQAI · Weight decrease · 2d
LG-Qraft's AI engine, which powers LQAI's selection of roughly 100 US large-cap core holdings, initiated consecutive reductions in PFIZER INC's weight, notably on June 11th and 12th. The fund's weekly rebalance cadence permits its AI-driven system to quickly adjust positions based on evolving assessments, reflecting a shift in PFE's ranking within the AI's proprietary model. This repositioning likely reflects the AI's assessment of PFE's recent performance, considering its 90-day return showing a decline of 2.1%. Given LQAI's AI-driven name selection aims for a core large-cap style without heavy factor tilt, the system likely interpreted such price trends in conjunction with other metrics, leading to the sustained reduction in PFE exposure.
weight 1.790% → 1.750% (-0.040 pp)·stock up 1.0% in the 30 days before
Jun 12·entry $26.21·now $24.75
-5.57%
since Jun 12
LQAI · Weight increase · 2d
Currently priced at $25.60, Pfizer trades at 90% of its 52-week high, despite experiencing -2.5% and -4.0% returns over the last 30 and 90 days, respectively, against a positive 9.2% one-year return. This setup, where the stock maintains a higher valuation within its annual range despite short-term pullbacks, aligns with LQAI's core large-cap, AI-driven selection approach, which avoids heavy factor tilts and rebalances weekly. The Qraft AI engine, applying its ranking to a US large-cap core universe, sequentially increased Pfizer’s weight on June 8th, 9th, and 10th, indicating its model perceived accumulating fundamental value or potential stability. This continued allocation occurred despite a 1.36% revenue growth and an 8.37% ROE, with the company carrying a PER of 20.04 and a PBR of 1.64, suggesting the AI's algorithm prioritizes other signals or long-term stability characteristics within the Health Care sector over recent growth metrics alone for this large-cap.
weight 1.750% → 1.790% (+0.040 pp)·stock down 0.8% in the 30 days before
Jun 10·entry $25.60·now $24.75Fresh
-3.32%
since Jun 10
-4.95%
since Jun 5
-2.33%
since Jun 3
-3.13%
since Jun 2
-3.43%
since Jun 1
-5.46%
since May 29
-4.26%
since May 26
-4.44%
since May 22
AIEQ · Weight increase · 2d
PFE, trading at $25.05 and near the lower end of its 52-week range (88% of its 52-week high), has experienced negative returns across the 30-day (-2.5%), 90-day (-7.8%), and 1-year (-0.8%) periods. This price trajectory, combined with AIEQ's daily rebalancing model and emphasis on both fundamentals and sentiment, suggests a recent positive shift detected by its IBM Watson NLP system. Despite PFE's 1.36% revenue growth and 8.37% ROE, the continuous weight increases from 0.41% to 0.43% from July 14th to 17th indicate that the system likely identified increasingly favorable sentiment or new fundamental insights from its deep ingestion of news, filings, or social posts. The fund's algorithm appears to recognize a developing positive narrative for PFE, prompting these specific daily adjustments within its high-turnover portfolio of 140-180 US stocks.
weight 0.410% → 0.430% (+0.020 pp)·stock down 3.8% in the 30 days before
Jul 17·entry $25.05·now $24.75Fresh
-1.20%
since Jul 17
AIEQ · New entry · 1d
weight 0 → 0.420% (new)·stock down 6.8% in the 30 days before
Jul 1·entry $23.88·now $24.75Drifting
+3.64%
since Jul 1
AIVL · Weight increase · 2d
The observed pattern for PFE within AIVL displays subtle, incremental weight additions from July 6th through July 8th, moving from 0.1830% to 0.1883%, following earlier fluctuations. PFIZER INC, currently trading at $24.25, has experienced a -7.5% return over 30 days, positioning it near 85% of its 52-week high and closer to its $23.29 52-week low. This price depreciation, alongside a PBR of 1.64 and PER of 18.47, likely signals to WisdomTree's AI that the health care stock is presenting a more compelling valuation opportunity. The AI's process, designed to distinguish genuine value from value traps within a US value-factor pool using fundamentals like ROE of 8.37% and valuation metrics, appears to be acting on this enhanced valuation. This methodical adjustment reflects the fund's specific strategy of identifying value as prices become more appealing during its periodic rebalancing.
weight 0.183% → 0.188% (+0.005 pp)·stock down 7.6% in the 30 days before
Jul 8·entry $24.05·now $24.75Drifting
+2.91%
since Jul 8
AIVL · Weight decrease · 2d
PFE’s modest 1.36% Revenue Growth and 8.37% ROE, coupled with a PER of 18.46 and PBR of 1.64, positioned it within AIVL’s US value-factor pool, but likely prompted a re-evaluation by the AI. WisdomTree’s AI, designed to differentiate genuine value from value traps using fundamentals and valuation metrics, consistently reduced PFE's weight in AIVL from June 11 to June 25. This sustained divestment occurred as PFE’s price experienced a significant negative 5.7% 30-day return, nearing its 52-week low of $23.29. The AI’s action suggests that PFE's limited growth and return on equity no longer met the algorithm's criteria for a compelling value opportunity, signaling a diminished conviction in its relative score within the portfolio's universe.
weight 0.195% → 0.183% (-0.012 pp)·stock down 8.4% in the 30 days before
Jun 25·entry $23.67·now $24.75
+4.56%
since Jun 25
AIVL · Weight decrease · 4d
PFE’s stock price, currently at $25.08, trades at 88% of its 52-week high, having declined 9.6% over the last 90 days, despite a 1-year return of 4.6%. This price trajectory, alongside a P/E ratio of 18.94 and P/B of 1.64, likely influenced AIVL's AI, which evaluates fundamentals like the company’s 1.36% revenue growth and 8.37% return on equity. Within its value-factor universe, the WisdomTree AI's role is to distinguish genuine value from value traps; therefore, the consecutive weight decreases from 0.2121% to 0.1961% suggest its algorithms judged PFE's value proposition to be diminishing over this period. Even with the stock's recent price depreciation, the AI's models determined that PFE’s financial metrics, when cross-referenced with valuation, did not meet its evolving criteria for a durable value investment, leading to the sustained reduction in allocation.
weight 0.209% → 0.196% (-0.013 pp)·stock down 2.8% in the 30 days before
Jun 22·entry $25.08·now $24.75
-1.32%
since Jun 22
AIVL · Weight decrease · 3d
WisdomTree's AIVL, utilizing AI to distinguish genuine value from value traps within its roughly 100 US value stock universe, initiated a consistent reduction in its PFE allocation. The fund's methodology, which evaluates fundamentals and valuation metrics, likely flagged PFE due to its sluggish revenue growth of 1.36%. Despite a PBR of 1.64, the AI system appears to have deemed PFE's long-term prospects insufficient to maintain a higher weight within the portfolio. This periodic rebalancing action, shown by the continuous decrease from 0.2071% to 0.1985%, suggests the AI prioritized companies exhibiting stronger underlying business health over those with merely low valuation multiples.
weight 0.209% → 0.199% (-0.010 pp)·stock down 1.8% in the 30 days before
Jun 18·entry $25.21·now $24.75
-1.82%
since Jun 18
AIVL · Weight decrease · 2d
AIVL's AI, designed to distinguish genuine value from value traps within its roughly 100 US value stock universe, appears to be reducing its conviction in PFE. This reduction, observed through the consecutive weight decrease from 0.2088% on June 11 to 0.2040% by June 16, reflects the AI's periodic adjustments to its holdings. The algorithm, which assesses fundamentals like margins and return on capital alongside valuation metrics, may be signaling concerns despite PFE's 1.36% revenue growth. With PFE currently trading at 91% of its 52-week high and a P/E ratio of 20.04, the AI could be re-evaluating its relative appeal as a true value play at this elevated price level.
weight 0.209% → 0.204% (-0.005 pp)·stock up 2.8% in the 30 days before
Jun 16·entry $26.04·now $24.75
-4.95%
since Jun 16
-4.95%
since Jun 5
-2.33%
since Jun 3
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.